Projects per year
Personal profile
Research interests
Apoptosis in the immunesystem
specialisation
Apoptosis signaling in immunity
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
Eldering E.: Apoptosis regulation in immuno-hematology
Eldering, E., Kater, A. P., Slinger, E., Tonino, S., Wensveen, F., van der Windt, G., Derks, I., Terpstra, S., van Attekum, M., Brocco, F., Delgado, R., Hofland, T. & Leeksma, A.
1/01/2007 → …
Project: Research
-
Negligible role of TRAIL death receptors in cell death upon endoplasmic reticulum stress in B-cell malignancies
Favaro, F., Both, D., Derks, I. A. M., Spaargaren, M., Muñoz-Pinedo, C. & Eldering, E., 1 Dec 2023, In: Oncogenesis. 12, 1, 6.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
SMG1, a nonsense-mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myeloma
Leeksma, A. C., Derks, I. A. M., Garrick, B., Jongejan, A., Colombo, M., Bloedjes, T., Trowe, T., Leisten, J. C., Howarth, M., Malek, M., Mortensen, D. S., Blease, K., Groza, M. C., Narla, R. K., Loos, R., Kersten, M-J., Moerland, P. D., Guikema, J. E. J., Kater, A. P., Eldering, E., & 1 others, 18 Nov 2022, (E-pub ahead of print) In: Molecular Oncology.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
The Effect of SF3B1 Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in Cancer
Leeksma, A. C., Derks, I. A. M., Kasem, M. H., Kilic, E., de Klein, A., Jager, M. J., van de Loosdrecht, A. A., Jansen, J. H., Navrkalova, V., Faber, L. M., Zaborsky, N., Egle, A., Zenz, T., Pospisilova, S., Abdel-Wahab, O., Kater, A. P. & Eldering, E., 29 Jan 2021, In: Frontiers in Oncology. 10, 609409.Research output: Contribution to journal › Article › Academic › peer-review
Open Access13 Citations (Scopus) -
CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
Martens, A. W. J., Janssen, S. R., Derks, I. A. M., Adams Iii, H. C., Izhak, L., van Kampen, R., Tonino, S. H., Eldering, E., van der Windt, G. J. W. & Kater, A. P., 1 Jun 2020, In: Journal for Immunotherapy of Cancer. 8, 1Research output: Contribution to journal › Article › Academic › peer-review
Open Access17 Citations (Scopus) -
Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia
Thijssen, R., ter Burg, J., Garrick, B., van Bochove, G. G. W., Brown, J. R., Fernandes, S. M., Rodríguez, M. S., Michot, J-M., Hallek, M., Eichhorst, B., Reinhardt, H. C., Bendell, J., Derks, I. A. M., van Kampen, R. J. W., Hege, K., Kersten, M. J., Trowe, T., Filvaroff, E. H., Eldering, E. & Kater, A. P., 2016, In: Blood. 128, 4, p. 574-583Research output: Contribution to journal › Article › Academic › peer-review
59 Citations (Scopus)